Digital Rectal Exam Does Not Detect Early-Stage Prostate Cancer
Among men analyzed with DRE as a solitary screening test for prostate cancer, suspicious findings did not increase prostate cancer detection.
Among men analyzed with DRE as a solitary screening test for prostate cancer, suspicious findings did not increase prostate cancer detection.
Swedish studies reveal significantly elevated risks for myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.
New findings could have implications for the use of salvage therapies.
Trend may reflect increasing use of systemic immunotherapies as first-line treatments, according to investigators.
Updated analysis showed longer progression-free and overall survival for patients with advanced renal cell carcinoma.
In a study, partial vs radical cytoreductive nephrectomy for clear cell metastatic renal cell carcinoma was associated with a 54% decreased risk for other-cause mortality.
A recent systematic review and meta-analysis provides the most up-to-date evidence for performance of triplet therapy compared with API-based doublets in mCSPC.
Prostate cancer-specific mortality was low for men randomly assigned to active monitoring, prostatectomy, or radiotherapy.
A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.
Less high-grade disease recurrence and lower treatment discontinuation seen with gemcitabine and docetaxel versus bacillus Calmette-Guérin.